MicroRNAs: New Insights into Chronic Childhood Diseases

被引:24
|
作者
Omran, Ahmed [1 ,2 ]
Elimam, Dalia [1 ]
Yin, Fei [2 ]
机构
[1] Suez Canal Univ, Dept Pediat & Neonatol, Ismailia 41522, Egypt
[2] Cent South Univ, Xiangya Hosp, Dept Pediat, Changsha 410008, Hunan, Peoples R China
关键词
MESIAL TEMPORAL-LOBE; INDUCED COLLAGEN EXPRESSION; IMMATURE RAT MODEL; CYSTIC-FIBROSIS; EPITHELIAL-CELLS; INSULIN-RESISTANCE; DOWN-REGULATION; MESSENGER-RNA; UP-REGULATION; ASTHMA;
D O I
10.1155/2013/291826
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Chronic diseases are the major cause of morbidity and mortality worldwide and have shown increasing incidence rates among children in the last decades. Chronic illnesses in the pediatric population, even if well managed, affect social, psychological, and physical development and often limit education and active participation and increase the risk for health complications. The significant pediatric morbidity and mortality rates caused by chronic illnesses call for serious efforts toward better understanding of the pathogenesis of these disorders. Recent studies have shown the involvement of microRNAs (miRNAs) in various aspects of major pediatric chronic non-neoplastic diseases. This review focuses on the role of miRNAs in four major pediatric chronic diseases including bronchial asthma, diabetes mellitus, epilepsy and cystic fibrosis. We intend to emphasize the importance of miRNA-based research in combating these major disorders, as we believe this approach will result in novel therapies to aid securing normal development and to prevent disabilities in the pediatric population.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] MicroRNAs: Potential Biomarkers and Targets of Therapy in Allergic Diseases?
    Specjalski, Krzysztof
    Jassem, Ewa
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2019, 67 (04) : 213 - 223
  • [42] The regulatory role of microRNAs in angiogenesis-related diseases
    Sun, Li-Li
    Li, Wen-Dong
    Lei, Feng-Rui
    Li, Xiao-Qiang
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (10) : 4568 - 4587
  • [43] Lipoxygenases in chronic liver diseases: current insights and future perspectives
    Heinrich, Lena
    Booijink, Richell
    Khurana, Amit
    Weiskirchen, Ralf
    Bansal, Ruchi
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2022, 43 (03) : 188 - 205
  • [44] Stem Cell Treatment for Chronic Lung Diseases
    Tzouvelekis, Argyris
    Ntolios, Paschalis
    Bouros, Demosthenes
    RESPIRATION, 2013, 85 (03) : 179 - 192
  • [45] MicroRNAs in Vascular Eye Diseases
    Liu, Chi-Hsiu
    Huang, Shuo
    Britton, William R.
    Chen, Jing
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (02)
  • [46] Galectins testing: New promises for the diagnosis and risk stratification of chronic diseases?
    Gruson, Damien
    Ko, Gabriel
    CLINICAL BIOCHEMISTRY, 2012, 45 (10-11) : 719 - 726
  • [47] New insights into p53 functions through its target microRNAs
    Liao, Jun-Ming
    Cao, Bo
    Zhou, Xiang
    Lu, Hua
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2014, 6 (03) : 206 - 213
  • [48] New Insights on the Regulation of the Insulin-Degrading Enzyme: Role of microRNAs and RBPs
    Martin-Martin, Yolanda
    Perez-Garcia, Ana
    Torrecilla-Parra, Marta
    Fernandez-de Frutos, Mario
    Pardo-Marques, Virginia
    Jose Casarejos, Maria
    Busto, Rebeca
    Ramirez, Cristina M.
    CELLS, 2022, 11 (16)
  • [49] New insights into iNKT cells and their roles in liver diseases
    Gu, Xinyu
    Chu, Qingfei
    Ma, Xiao
    Wang, Jing
    Chen, Chao
    Guan, Jun
    Ren, Yanli
    Wu, Shanshan
    Zhu, Haihong
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [50] Association of birth and childhood weight with risk of chronic diseases and multimorbidity in adulthood
    Zhang, Yue
    Zhou, Yaguan
    Cheng, Yangyang
    Carrillo-Larco, Rodrigo M.
    Fawad, Muhammad
    Chen, Shu
    Xu, Xiaolin
    COMMUNICATIONS MEDICINE, 2023, 3 (01):